Cargando…
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
While reports suggest a single dose of senolytics may improve vasomotor function, the structural and functional impact of long‐term senolytic treatment is unknown. To determine whether long‐term senolytic treatment improves vasomotor function, vascular stiffness, and intimal plaque size and composit...
Autores principales: | Roos, Carolyn M., Zhang, Bin, Palmer, Allyson K., Ogrodnik, Mikolaj B., Pirtskhalava, Tamar, Thalji, Nassir M., Hagler, Michael, Jurk, Diana, Smith, Leslie A., Casaclang‐Verzosa, Grace, Zhu, Yi, Schafer, Marissa J., Tchkonia, Tamara, Kirkland, James L., Miller, Jordan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013022/ https://www.ncbi.nlm.nih.gov/pubmed/26864908 http://dx.doi.org/10.1111/acel.12458 |
Ejemplares similares
-
Deleted in Breast Cancer 1 regulates cellular senescence during obesity
por: Escande, Carlos, et al.
Publicado: (2014) -
Senolytics: Potential for Alleviating Diabetes and Its Complications
por: Palmer, Allyson K, et al.
Publicado: (2021) -
Senolytics alleviate the degenerative disorders of temporomandibular joint in old age
por: Zhou, Yueying, et al.
Publicado: (2021) -
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022) -
Transplanting cells from old but not young donors causes physical dysfunction in older recipients
por: Wang, Binsheng, et al.
Publicado: (2020)